WEBULL
WebtradeDownload

HCA Healthcare (HCA) Stock May Trade At A Discount Despite Cape Coral Hospital Incentives

Simply Wall St · 2d ago

HCA Healthcare stock has more than doubled in recent years, and with the shares last closing at US$465.26, the key question is whether that price is fully backed by the cash the business can generate over time. With investors also digesting fresh expansion news, the focus now turns to what HCA Healthcare's cash flows suggest about where value really sits.

  • HCA Healthcare has delivered a 113.1% return over the past 3 years, which puts a lot of investor expectations on whether its future cash flows can keep underpinning that kind of share price performance.
  • The newly approved US$31m in incentives for a 100 bed hospital in Cape Coral may support longer term revenue and cash generation, while also adding upfront investment needs and timing questions around when those cash flows arrive.
  • What if you looked at HCA Healthcare through its earnings instead? See what HCA Healthcare's 14.7x P/E says about the price.

The stock's next move may depend on whether that recent price of US$465.26 is well supported by HCA Healthcare's intrinsic value based on its cash flows.

If you want more ideas with a similar cash flow focus, a good next step is to scan 29 high quality undervalued stocks as another starting point for your research.

Is HCA Healthcare Still Cheap on Cash Flow?

The Discounted Cash Flow (DCF) approach here looks at the cash HCA Healthcare can return to shareholders over time, then adjusts those amounts back to today’s dollars. On this model, the business generated last twelve month free cash flow of about $6.0b, with projections implying growing cash generation through to 2030 and then a slower, more mature expansion path after that.

The DCF projections put HCA Healthcare's estimated intrinsic value substantially above the current share price of US$465.26. Because the Cape Coral hospital incentives concentrate more capital into a region that is already expanding, the market may still be discounting how those extra projected cash flows feed into long term value once the facility opens. Find out what HCA Healthcare could be worth using our Discounted Cash Flow (DCF) estimate.

The HCA Healthcare Narrative: What Would Justify Today's Price?

Simply Wall St Narratives pick up where the cash flow puzzle leaves off for HCA Healthcare by spelling out which paths for revenue trends, margins and earnings would need to play out for the stock to be worth significantly more or less than today’s price. Each one presents HCA Healthcare's fair value as a thesis you can track over time rather than a single frozen snapshot on the Community page.

Community views on HCA Healthcare split between those who see durable cash generation and scale as underappreciated and others who think most of that strength is already reflected in the price.

Bull case: 26% undervalued

"HCA’s footprint is enormous, with hospitals, surgery centers, and outpatient facilities spread across the U.S., the company benefits from scale..."

Discover why this Narrative puts HCA Healthcare at 26% undervalued.

Bear case: roughly fairly valued

"Persistent uncertainty and potential negative impacts of the evolving federal policy environment remain a live issue, as the expiration of enhanced exchange tax credits has already led to a large shift from insured to uninsured patients..."

Explore why this Narrative puts HCA Healthcare at roughly fairly valued.

One more HCA Healthcare factor to check before you act

Cash flows and valuation models only tell part of the story for HCA Healthcare, because the people steering the business and the way their pay is structured can heavily influence what happens next. See who runs HCA Healthcare and how they are paid.